“Estimated Conjunctivitis-Related Healthcare Cost Savings With Increased Tralokinumab Use Versus Other Biologics Among Patients With Moderate-Severe Atopic Dermatitis in the United States”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 6, Nov. 2025, p. s630, https://doi.org/10.25251/ej4zcr36.